We are live on ! Find out more
MF

Manchester Financial Portfolio holdings

AUM $563M
1-Year Est. Return 21.72%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+21.72%
3 Year Est. Return
+67.54%
5 Year Est. Return
+58.71%
10 Year Est. Return
AUM
$161M
AUM Growth
+$29.4M
Cap. Flow
+$10.1M
Cap. Flow %
6.3%
Top 10 Hldgs %
55.6%
Holding
681
New
89
Increased
134
Reduced
90
Closed
40

Sector Composition

Rank Sector Weight
1 Technology 14.17%
2 Financials 6.45%
3 Communication Services 5.9%
4 Consumer Discretionary 5.32%
5 Healthcare 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
676
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$0 ﹤0.01%
80
BSTC
677
DELISTED
BioSpecifics Technologies Corp.
BSTC
-2,954
Closed -$156K
GPOR
678
DELISTED
Gulfport Energy Corp.
GPOR
-600
Closed
IMMU
679
DELISTED
Immunomedics Inc
IMMU
-500
Closed -$43K
RST
680
DELISTED
ROSETTA STONE INC
RST
-1,000
Closed -$30K
MNK
681
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-1
Closed

Similar funds

Manchester Financial's Q4 2020 Portfolio in Review

As of Q4 2020, Manchester Financial held 681 positions worth $161M, up 22% from $132M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Manchester Financial deployed $10.1M of net new capital in Q4 2020, opening 89 new positions and adding to 134 existing holdings. Its largest new stake was iShares US Medical Devices ETF: 83,514 shares worth $4.56M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $9.61M trimmed.

  • Manchester Financial's largest Q4 2020 buy was iShares US Medical Devices ETF: 83,514 shares worth $4.56M.
  • Manchester Financial added most to Schwab US Mid-Cap ETF in Q4 2020, an estimated $8.62M increase.
  • Manchester Financial's biggest Q4 2020 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $9.61M.
  • Manchester Financial fully exited BioSpecifics Technologies Corp. in Q4 2020, selling an estimated $156K.
  • Manchester Financial's ten largest holdings make up 56% of its $161M portfolio in Q4 2020.
  • Manchester Financial opened 89 new positions and closed 40 in Q4 2020.
  • Manchester Financial's portfolio value rose 22% quarter-over-quarter to $161M.

Based on Manchester Financial's 13F filing for Q4 2020, filed 26 Jan 2021.